BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9356876)

  • 1. Bile duct carcinoma without jaundice: clues to early diagnosis.
    Sugiyama M; Atomi Y; Kuroda A; Muto T
    Hepatogastroenterology; 1997; 44(17):1477-83. PubMed ID: 9356876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological feature of extrahepatic cholangiocarcinoma without jaundice: a single-center experience.
    Ito Y; Kenmochi T; Irino T; Egawa T; Hayashi S; Nagashima A; Kitagawa Y
    Hepatogastroenterology; 2012 Sep; 59(118):1744-7. PubMed ID: 22389267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma.
    Yang WL; Zhang XC; Zhang DW; Tong BF
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):631-5. PubMed ID: 18086631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of extrahepatic bile-duct carcinomas in the nonicteric stage by using MRCP followed by EUS.
    Sai JK; Suyama M; Kubokawa Y; Watanabe S; Maehara T
    Gastrointest Endosc; 2009 Jul; 70(1):29-36. PubMed ID: 19286177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological analysis of cystic duct carcinoma.
    Chan KM; Yeh TS; Tseng JH; Liu NJ; Jan YY; Chen MF
    Hepatogastroenterology; 2005; 52(63):691-4. PubMed ID: 15966184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and surgical features of Klatskin tumors.
    Santoro E; Sacchi M; Carboni F; Santoro R; Scardamaglia F
    Chir Ital; 1999; 51(1):1-7. PubMed ID: 10514910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological features of primary carcinoma of the cystic duct.
    Nakata T; Kobayashi A; Miwa S; Soeda J; Uehara T; Miyagawa S
    J Hepatobiliary Pancreat Surg; 2009; 16(1):75-82. PubMed ID: 19096752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment of cholangiocellular carcinoma and proximal bile duct tumors].
    Lorf T; Hanack U; Schwörer H; Sattler B; Ringe B
    Zentralbl Chir; 2000; 125(7):637-41. PubMed ID: 10960975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of hilar bile duct carcinoma. Clinical and pathological studies.
    Huang ZQ; Zhou NX; Liu YX; Li WH; Yu G
    Chin Med J (Engl); 1992 Aug; 105(8):635-40. PubMed ID: 1458965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of percutaneous transhepatic cholangioscopy for the diagnosis of the intramural extension of bile duct carcinoma.
    Sato M; Inoue H; Ogawa S; Ohashi S; Maetani I; Igarashi Y; Sakai Y
    Endoscopy; 1998 Mar; 30(3):281-8. PubMed ID: 9615877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
    Shi QF; Liang TB; Qin YS; Wang WL; Shen Y; Zhang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):622-6. PubMed ID: 18086629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
    Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases.
    Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine tumors of the extrahepatic bile ducts. Pathological and clinical aspects, surgical management and outcome.
    El Rassi ZS; Mohsine RM; Berger F; Thierry P; Partensky CC
    Hepatogastroenterology; 2004; 51(59):1295-300. PubMed ID: 15362737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for cholangiocarcinoma.
    Franco D; Usatoff V
    Hepatogastroenterology; 2001; 48(37):53-5. PubMed ID: 11268998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case.
    Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T
    Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.